| Year |
Citation |
Score |
| 2016 |
Guinney J, Wang T, Laajala TD, Winner KK, Bare JC, Neto EC, Khan SA, Peddinti G, Airola A, Pahikkala T, Mirtti T, Yu T, Bot BM, Shen L, Abdallah K, et al. Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data. The Lancet. Oncology. PMID 27864015 DOI: 10.1016/S1470-2045(16)30560-5 |
0.452 |
|
| 2016 |
Zhou FL, Guinney J, Wang T, Bare JC, Norman TC, Bot B, Shen L, Winner KK, Friend SH, Abdallah K, Stolovitzky GA, Xie Y, Costello J. Use of crowdsourced research to develop a prognostic model for first-line metastatic castrate resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 34: 180-180. DOI: 10.1200/Jco.2016.34.2_Suppl.180 |
0.449 |
|
| 2015 |
Steinkamp MP, Winner KK, Moses M, Jiang Y, Wilson BS. Abstract POSTER-TECH-1124: Modeling antibody penetration into metastatic ovarian tumors after intravenous or intraperitoneal delivery Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Ovcasymp14-Poster-Tech-1124 |
0.463 |
|
| 2015 |
Guinney J, Wang T, Bare C, Norman T, Bot B, Shen L, Winner K, Friend S, Abdallah K, Stolovitzky G, Xie Y, Zhou FL, Costello JC. Abstract B204: A DREAM Challenge to improve prognostic models in patients with metastatic castrate-resistant prostate cancer Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-B204 |
0.485 |
|
| 2013 |
Steinkamp MP, Winner KK, Davies S, Muller C, Zhang Y, Hoffman RM, Shirinifard A, Moses M, Jiang Y, Wilson BS. Ovarian tumor attachment, invasion, and vascularization reflect unique microenvironments in the peritoneum: insights from xenograft and mathematical models. Frontiers in Oncology. 3: 97. PMID 23730620 DOI: 10.3389/Fonc.2013.00097 |
0.372 |
|
| Show low-probability matches. |